Clin2
NCT07167381Possibly a fitRecruiting

Tumor testing to find cancer treatments for Florida patients

CancerNeoplamsRefractoryRecurrenceLeukaemiaLymphomaSolid Tumor MalignanciesSolid Cancers

Part of Blood & lymphatic, Cancer, Immune system & allergy clinical trials.

This study tests your tumor sample to find which drugs might work best for your cancer. It is for both children and adults whose cancer has come back or not responded to treatment, and who have already tried at least one standard therapy.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
210 people
Ages
Any age
Study type
Interventional

Who can take part

  • You must have cancer that came back or did not get better after treatment.
  • Children up to age 18 or adults 18 and older can join.
  • You must have had at least one standard cancer treatment before.
  • You need to be well enough to have a tumor sample taken (biopsy or surgery).
  • You will need to give a blood or cheek swab sample for comparison.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT04723316Recruiting
Tumor testing to guide targeted cancer treatment

This trial looks at your tumor (and blood) to find helpful targets so doctors can match you to an experimental targeted therapy, if one fits. It may help by using detailed “tumor profiling” to choose treatments more precisely for your cancer.

Belfast
NCT03089554Recruiting· Phase 2
Genetic tumor testing to guide targeted cancer treatments

This trial studies how doing genetic (DNA) testing on your cancer helps doctors choose targeted treatments, and how those treatments affect outcomes. It is for adults whose cancer has not responded to the first standard treatment or who do not have curative options.

Lexington, Kentucky
NCT02090530Recruiting
Precision testing of tumor tissue for advanced cancers

This study uses advanced DNA testing on tumor samples to help match cancer treatments more precisely. It may help researchers learn which cancer changes are driving your tumor and how they relate to treatment choices.

Columbus, Ohio
NCT07264803Recruiting· Phase 2
Tumor testing to guide treatment for advanced cancers

This trial uses a patient's own tumor tissue to test which drugs might work best for cancers that have returned or not responded to previous treatments. It focuses on advanced gastric cancer and other solid tumors.

Jinan, Shandong
NCT05857969Recruiting· Phase 1
Testing cancer drug response on removed tumor tissue

This early study uses tumor tissue (or bone marrow from blood cancers) and performs lab tests to see which cancer drugs may work better for each person. It also collects genetic information from blood or a saliva swab to help understand why cancers respond differently.

Miami, Florida
NCT06782451Recruiting
Testing tumor samples to find new treatments based on DNA changes

This trial takes a sample of your tumor during a standard procedure to grow it in a lab and test different drugs. The goal is to find which drugs might work best for people with your specific tumor DNA change.

Nice

Hear when a new Cancer trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.